MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP - PubMed (original) (raw)

MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP

Kenji Deguchi et al. Cancer Cell. 2003 Mar.

Free article

Abstract

The MOZ-TIF2 fusion is associated with acute myeloid leukemia (AML) with inv(8)(p11q13). MOZ is a MYST family histone acetyltransferase (HAT), whereas TIF2 is a nuclear receptor coactivator that associates with CREB binding protein (CBP). Here we demonstrate that MOZ-TIF2 has transforming properties in vitro and causes AML in a murine bone marrow transplant assay. The C2HC nucleosome recognition motif of MOZ is essential for transformation, whereas MOZ HAT activity is dispensable. However, MOZ-TIF2 interaction with CBP through the TIF2 CBP interaction domain (CID) is essential for transformation. These results indicate that nucleosomal targeting by MOZ and recruitment of CBP by TIF2 are critical requirements for MOZ-TIF2 transformation and indicate that MOZ gain of function contributes to leukemogenesis.

PubMed Disclaimer

Cited by

The lysine acetyltransferase activator Brpf1 governs dentate gyrus development through neural stem cells and progenitors.
You L, Yan K, Zou J, Zhao H, Bertos NR, Park M, Wang E, Yang XJ. You L, et al. PLoS Genet. 2015 Mar 10;11(3):e1005034. doi: 10.1371/journal.pgen.1005034. eCollection 2015 Mar. PLoS Genet. 2015. PMID: 25757017 Free PMC article.
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.
Krivtsov AV, Evans K, Gadrey JY, Eschle BK, Hatton C, Uckelmann HJ, Ross KN, Perner F, Olsen SN, Pritchard T, McDermott L, Jones CD, Jing D, Braytee A, Chacon D, Earley E, McKeever BM, Claremon D, Gifford AJ, Lee HJ, Teicher BA, Pimanda JE, Beck D, Perry JA, Smith MA, McGeehan GM, Lock RB, Armstrong SA. Krivtsov AV, et al. Cancer Cell. 2019 Dec 9;36(6):660-673.e11. doi: 10.1016/j.ccell.2019.11.001. Cancer Cell. 2019. PMID: 31821784 Free PMC article.
Zebrafish as a model for leukemia and other hematopoietic disorders.
Rasighaemi P, Basheer F, Liongue C, Ward AC. Rasighaemi P, et al. J Hematol Oncol. 2015 Mar 28;8:29. doi: 10.1186/s13045-015-0126-4. J Hematol Oncol. 2015. PMID: 25884214 Free PMC article. Review.
The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target.
Di Martile M, Del Bufalo D, Trisciuoglio D. Di Martile M, et al. Oncotarget. 2016 Aug 23;7(34):55789-55810. doi: 10.18632/oncotarget.10048. Oncotarget. 2016. PMID: 27322556 Free PMC article. Review.
NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesis.
Hayashi Y, Harada Y, Kagiyama Y, Nishikawa S, Ding Y, Imagawa J, Shingai N, Kato N, Kitaura J, Hokaiwado S, Maemoto Y, Ito A, Matsui H, Kitabayashi I, Iwama A, Komatsu N, Kitamura T, Harada H. Hayashi Y, et al. Blood Adv. 2019 Apr 9;3(7):1047-1060. doi: 10.1182/bloodadvances.2018025007. Blood Adv. 2019. PMID: 30944097 Free PMC article.

MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP - PubMed (original) (raw)